Related Experiment Video
Updated: Jan 9, 2026

An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice
Published on: March 19, 2018
Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes
Jan-Malte Sinning1, Jan Losch, Katrin Walenta
1Medizinische Klinik und Poliklinik II, Universitätsklinikum Bonn, Sigmund-Freud-Str. 25, 53105, Bonn, Germany.
Insights
Elevated CD31+/Annexin V+ microparticles (MPs) predict cardiovascular events in patients with stable coronary artery disease (CAD). These microparticles may improve risk assessment for major adverse cardiovascular and cerebral events (MACCE).
Area of Science:
- Cardiovascular Medicine
- Biomarker Discovery
- Clinical Research
Background:
- CD31+/Annexin V+ microparticles (MPs) are elevated in individuals with cardiovascular risk factors and impaired endothelial function.
- Previous studies suggest a link between MPs and endothelial dysfunction.
Purpose of the Study:
- To determine if CD31+/Annexin V+ MPs serve as an independent predictor of cardiovascular events in patients with stable coronary artery disease (CAD).
- To assess the utility of MPs in cardiovascular risk stratification for CAD patients.
Main Methods:
- Flow cytometry was used to quantify CD31+/Annexin V+ MP levels in 200 stable CAD patients.
- Patients were followed for a median of 6.1 years for major adverse cardiovascular and cerebral events (MACCE).
- Multivariate analysis was performed, adjusting for traditional cardiovascular risk factors.
Main Results:
- Higher MP levels were observed in patients who experienced MACCE compared to those who did not (P=0.004).
- Elevated MP levels were independently associated with increased risk of cardiovascular death (HR 4.0), revascularization (HR 2.4), and first MACCE (HR 2.3).
- Inclusion of MP levels improved the predictive accuracy of a traditional cardiovascular risk model (c-statistic increased from 0.637 to 0.702).
Conclusions:
- Circulating CD31+/Annexin V+ MPs are an independent predictor of cardiovascular events in stable CAD.
- MP levels may enhance the risk stratification of patients with stable coronary artery disease.
Aims:
CD31+/Annexin V+ microparticles (MPs) are increased in patients with cardiovascular risk factors and impaired coronary endothelial function. We evaluated whether MPs are an independent marker for cardiovascular events in patients with stable coronary artery disease (CAD).
Methods And Results:
The number of CD31+/Annexin V+ MP was determined by flow cytometry in 200 patients (age 66.1±10.4 years) and correlated with cardiovascular outcomes. The median follow-up time for major adverse cardiovascular and cerebral event (MACCE)-free survival was 6.1 (6.0/6.4) years. Four patients were lost to follow-up. A first MACCE occurred in 72 patients (37%). Microparticle levels were significantly higher in patients with MACCE compared with patients without event (P=0.004). The prevalence of diabetes (P=0.02) and male gender (P=0.05) was significantly related to the MP level. In multivariate analysis (cardiovascular risk factors, number of diseased vessels, use of angiotensin-converting enzyme-inhibitors and statins), high MP levels were associated with a higher risk for cardiovascular death [Hazard ratio (HR) 4.0, 95% confidence interval (CI) 1.1-14.6; P=0.04], the need for revascularization (HR 2.4, 95% CI 1.3-4.4; P=0.005), and the occurrence of a first MACCE (HR 2.3, 95% CI 1.4-3.8; P=0.001). Inclusion of the MP level into a classical risk factor model substantially increased c-statistics from 0.637 (95% CI: 0.557-0.717) to 0.702 (95% CI: 0.625-0.780) (P=0.03).
Conclusion:
The level of circulating CD31+/Annexin V+ MPs is an independent predictor of cardiovascular events in stable CAD patients and may be useful for risk stratification.
Related Concept Videos
06:40An Improved Method for Collection of Cerebrospinal Fluid from Anesthetized Mice
08:40Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure
11:47Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
11:56A Rapid and Specific Microplate Assay for the Determination of Intra- and Extracellular Ascorbate in Cultured Cells
14:55Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System

